ESC 365 - Increase of beta-blocker dose and QT interval in heart failure - do we really know it all by heart? Results from CIBIS ELD study.

HFA Premium Access

Increase of beta-blocker dose and QT interval in heart failure - do we really know it all by heart? Results from CIBIS ELD study.

Session: Poster Session 2 - Beta blockers

Topic: Beta blockers

Speaker: Professor S. Apostolovic (Nis, RS)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Professor Svetlana Apostolovic

Clinical Center of Nis, Nis (Serbia)

1 follower

5 more presentations in this session

Beneficial effects of beta-blockers and ivabradine combination in patients hospitalized due to worsening of heart failure: findings from

Speaker: Professor Y. Lopatin (Volgograd, RU)

Are beta-blockers effective in children with congestive heart failure? - A Cochrane review

Speaker: Doctor S. Alabed (Sheffield, GB)

Quality of life is similar in patients with chronic stable heart failure on vasodilating and non-vasodilating beta blockers.

Speaker: Doctor R. Pharithi (London, GB)

The impact of 12 month beta-blocker therapy on left and right ventricular volumes and ejection fraction and functional status of heart failure patients with midrange ejection fraction

Speaker: Professor M. Poltavskaya (Moscow, RU)

Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure

Speaker: Doctor H. Froehlich (Heidelberg, DE)

Access the full session

Poster Session 2 - Beta blockers

Speakers: Professor S. Apostolovic, Professor Y. Lopatin, Doctor S. Alabed, Doctor R. Pharithi, Professor M. Poltavskaya...

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources